ARS Pharmaceuticals, Inc.

SPRYNasdaq· Pharmaceutical Preparations

Price History

Revenue

$84.3M

▼ 5.5% YoY

Net Income

-$171.3M

▼ 2241.8% YoY

EPS

$-1.74

▼ 2275.0% YoY

Cash

$41.3M

▼ 18.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.